Negative Vaccination by Specific CD4+ T Cell Tolerisation Enhances Virus-Specific Protective Antibody Responses
2007

Negative Vaccination Enhances Antibody Responses

Sample size: 5 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lang Karl S., Hegazy Ahmed N., Lang Philipp A., Eschli Bruno, Löhning Max, Hengartner Hans, Zinkernagel Rolf M., Recher Mike

Primary Institution: Institute of Experimental Immunology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland

Hypothesis

Can specific CD4+ T cell tolerisation enhance virus-specific protective antibody responses?

Conclusion

Specific CD4+ T cell unresponsiveness can enhance protective antibody responses in chronic virus infections.

Supporting Evidence

  • Peptide tolerisation led to enhanced virus-specific neutralizing antibody responses.
  • CD8+ T cell responses were not impaired by CD4+ T cell tolerisation.
  • Third-party immune responses were unaffected by the tolerisation strategy.

Takeaway

This study shows that making certain immune cells less responsive can actually help the body make better antibodies against viruses.

Methodology

Mice were treated with LCMV-derived peptides to induce CD4+ T cell tolerisation and then infected with LCMV to assess antibody responses.

Limitations

The study primarily focuses on a mouse model, which may not fully represent human immune responses.

Participant Demographics

C57BL/6 mice were used in the experiments.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001162

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication